Catheter ablation for ventricular tachyarrhythmia in patients with channelopathies

Drug treatment and/or implantable cardioverter defibrillator (ICD) implantation are the most widely accepted first-line therapies for channelopathic patients who have recurrent syncope, sustained ventricular tachycardia (VT), or documented ventricular fibrillation (VF), or are survivors of cardiac a...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakoshi, Nobuyuki, Aonuma, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063265/
https://www.ncbi.nlm.nih.gov/pubmed/27761165
http://dx.doi.org/10.1016/j.joa.2016.01.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063265/
https://www.ncbi.nlm.nih.gov/pubmed/27761165
http://dx.doi.org/10.1016/j.joa.2016.01.011

Ejemplares similares